Drug Shortage Report for PRO-RABEPRAZOLE

Last updated on 2023-07-11 History
Report ID 93043
Drug Identification Number 02315181
Brand name PRO-RABEPRAZOLE
Common or Proper name PRO-RABEPRAZOLE
Company Name PRO DOC LIMITEE
Market Status CANCELLED POST MARKET
Active Ingredient(s) RABEPRAZOLE SODIUM
Strength(s) 10MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-12-31
Actual start date 2020-01-07
Estimated end date Unknown
Actual end date 2023-07-10
Shortage status Resolved
Updated date 2023-07-11
Company comments Discontinued as of July 10, 2023 – Discontinué en date du 10 juillet 2023.
Health Canada comments
Tier 3 Status No
Contact Address 2925 BOULEVARD INDUSTRIEL
LAVAL, QUEBEC
CANADA H7L 3W9
Company contact information 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-09-05 English Compare
v2 2019-09-05 French Compare
v3 2020-01-01 English Compare
v4 2020-01-07 English Compare
v5 2020-01-07 French Compare
v6 2020-01-08 English Compare
v7 2023-07-11 English Compare
v8 2023-07-11 French Compare

Showing 1 to 8 of 8